Chemistry Reference
In-Depth Information
175. Saarela, M. et al., Probiotic bacteria: Safety, functional and technological properties,
J.
Biotech.
, 84,197,2000.
176. Henriksson, A., Borody, T., and Clancy, R., Probiotics under the regulatory microscope,
Expert Opin. Drug Saf.,
4,1135,2005.
177. Prakash, S. and Martoni, C., Toward a new generation of therapeutics: Artificial cell
targeted delivery of live cells for therapy,
Appl. Biochem. Biotechnol.,
128,1,2006.
178. Kim, N. et al., Oral feeding of
Bifidobacterium
bifidum
(BGN4) prevents CD4(+)
CD45RB(high) T-cell-mediated inflammatory bowel disease by inhibition of disordered
T cell activation,
Clin. Immunol.,
123,30,2007.
179. Geier, M.S. et al.,
Lactobacillus fermentum
br11, a potential new probiotic, allevi-
ates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats,
Int. J. Food
Microbiol.,
114,267,2007.
180. Fan, Y.J. et al., A probiotic treatment containing
Lactobacillus, Bifidobacterium
and
Enterococcus
improves IBS symptoms in an open label trial,
J. Zhejiang Univ. Sci.
B.,
7,987,2006.
181. Astegiano, M. et al., Treatment of irritable bowel syndrome. A case control experience,
Minerva Gastroenterol. Dietol.,
52,349,2006.
182. Colecchia, A. et al., Effect of a symbiotic preparation on the clinical manifestations of
irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multi-
center study,
Minerva Gastroenterol. Dietol.,
52,359,2006.
183. Campieri, M., Rizzello, F., and Venturi, A., Combination of antibiotic and probiotic
treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease:
A randomized controlled study vs. mesalamine,
Gastroenterology,
118,G4179,2000.